about
Antitumoral effect of vanadium compounds in malignant melanoma cell lines.Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties.Potentiometric and spectroscopic studies on the copper(II) complexes of rat amylin fragments. The anchoring ability of specific non-coordinating side chains.Copper(II) and nickel(II) binding sites of peptide containing adjacent histidyl residues.Characterization and biotransformation in the plasma and red blood cells of V(IV)O(2+) complexes formed by ceftriaxone.Synthesis of Nitric Oxide Donors Derived from Piloty's Acid and Study of Their Effects on Dopamine Secretion from PC12 CellsHistamine modified 2'-deoxyriboadenosine--potential copper binding site in DNAzymes.Development and characterization of an ascorbate oxidase-based sensor-biosensor system for telemetric detection of AA and antioxidant capacity in fresh orange juice.Impact of 1,5-disubstituted tetrazole ring on chelating ability of delta-selective opioid peptide.Copper(II) complexes of rat amylin fragments.Acid-base properties and copper(II) complexes of dipeptides containing histidine and additional chelating bis(imidazol-2-yl) residues.Complex formation of vanadium(IV) with 1,3,5-triamino-1,3,5-trideoxy-cis-inositol and related ligands.Complex formation processes of terminally protected peptides containing two or three histidyl residues. Characterization of the mixed metal complexes of peptides.Formation in aqueous solution of a non-oxido V(IV) complex with VN6 coordination. Potentiometric, ESI-MS, spectroscopic and computational characterization.On the transport of vanadium in blood serum.Interaction of copper(II) with the prion peptide fragment HuPrP(76-114) encompassing four histidyl residues within and outside the octarepeat domain.Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations.Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.Speciation of potential anti-diabetic vanadium complexes in real serum samples.Potentiometric, spectroscopic, electrochemical and DFT characterization of oxovanadium(IV) complexes formed by citrate and tartrates in aqueous solution at high ligand to metal molar ratios: the effects of the trigonal bipyramidal distortion in bis-Nonoxido V(IV) Complexes: Prediction of the EPR Spectrum and Electronic Structure of Simple Coordination Compounds and Amavadin.Copper(II) complexes of oligopeptides containing aspartyl and glutamyl residues. Potentiometric and spectroscopic studies.Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 3. Antioxidant properties and radical production capability.Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride.Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies.Speciation of the Potential Antitumor Agent Vanadocene Dichloride in the Blood Plasma and Model Systems.DNA binding and cleavage studies of copper(II) complexes with 2'-deoxyadenosine modified histidine moiety.Behavior of the potential antitumor V(IV)O complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH.Synthesis and characterization of V(IV)O complexes of picolinate and pyrazine derivatives. Behavior in the solid state and aqueous solution and biotransformation in the presence of blood plasma proteins.Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes.Interaction of insulin-enhancing vanadium compounds with human serum holo-transferrin.VIVO complexes with antibacterial quinolone ligands and their interaction with serum proteins.Influence of pH, buffers and role of quinolinic acid, a novel iron chelating agent, in the determination of hydroxyl radical scavenging activity of plant extracts by Electron Paramagnetic Resonance (EPR).Interaction of VO2+ ion with human serum transferrin and albumin.Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1H)-one, with Al(III), Cu(II) and Zn(II) ions.Decoding Surface Interaction of VIVO Metallodrug Candidates with Lysozyme.Application of DFT methods to the study of the coordination environment of the VO2+ ion in V proteins.Simultaneous amperometric detection of ascorbic acid and antioxidant capacity in orange, blueberry and kiwi juice, by a telemetric system coupled with a fullerene- or nanotubes-modified ascorbate subtractive biosensorEnvironmental Effects on a Prion's Helix II Domain: Copper(II) and Membrane Interactions with PrP180–193 and Its AnaloguesVIVO and CuII complexation by ligands based on pyridine nitrogen donors
P50
Q38701856-2ECC20AF-9D7F-49E9-9763-924DEC29E852Q39156104-9B286748-38E8-4008-A21A-38C185B3E794Q40540456-9C5F6B7B-02D0-4FC1-AC74-5AC454B06C5BQ40721669-7BB91EDD-0A90-4D80-8343-5052914EEBB9Q41560185-31B77DEF-B3D3-4CA2-885C-870EAF3355D2Q41877565-BCD28202-2E20-4F4E-90BE-59E89AA6313CQ43156199-09FF89E8-76AF-4DD0-9ACA-F2E3505A51CEQ43492781-01893E78-A478-4D19-972D-AE2473B01168Q44344639-92497B3D-A524-48F5-BBC1-8FCF90E4712FQ44409592-22EA3364-BF21-4CC1-BE01-BE7D9DECD319Q44682664-7CE73581-54D0-45C0-BE7C-C44C6AB18214Q44887664-504250B7-3032-40BD-B11A-87CBAA09B865Q45382039-AC2724B1-A792-4CBB-A668-F4B093739636Q45423532-68D5E11D-C922-40A2-B2BD-A9F9487DA572Q45974824-DEE597B4-EC56-4544-80B9-44F1D207C972Q46028481-AA60C9BF-8D50-477B-841B-DA88D96DC345Q46292820-3D5BB3D5-49E6-4B4D-B80D-638821E2E7DAQ46346192-B0B778A3-2AF9-4C76-AFBA-0EB6EF20F351Q46366918-2DAE8A15-7DED-42A7-8AB9-2F920F9543C7Q46394659-1839E87A-CC1A-495D-9ACC-03E05B48FD0AQ46518261-5A10181C-5846-49F4-9768-BE612CA784E9Q46519938-039F3B66-E1F7-4685-8122-7F3EF53A081FQ46547649-37B7B08C-3C93-4AC8-9C75-317A4D69C257Q46556968-3A0CCAF7-629D-4CF9-931C-25FD6B9459EDQ46683303-A781FC81-B829-4051-AA97-EF87DC3CCBA9Q46683447-D443E139-AD0A-4633-AAD8-2008347FB665Q46698926-D6213533-636C-43EA-A38A-5DA3E6B69227Q46851740-12B5C953-33C3-453D-B668-67CB85D76B07Q46867884-C5EE1A88-1245-4870-B5DD-714422BC6722Q46944893-95818637-6D79-4C05-8498-F7E587C51B48Q46987554-83BF2365-513C-42D4-A31F-52A6DAD304A6Q47720108-91FABBC2-45CD-41A9-AEF5-6F97265D36AAQ50188975-8593D8BD-958F-446D-8A72-D9CBAFB693F9Q51833827-1E142D93-36E1-4949-951E-77949A25C4B0Q52696614-F4608205-F44E-400C-A7B1-244E7D577BF8Q53824148-76DFB913-A03D-46FD-AF86-80F866704A8DQ54515525-BD44D67E-E646-4CE1-A1FF-A6DE84A28BA0Q57762478-AA67A734-4E33-4579-B2CB-05B2CF51DCD4Q57851762-E0663E37-1DD4-48C0-A779-27FD4B9D71C4Q59082951-A72D2ACF-F76D-4F27-8301-72A22A18F3C0
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniele Sanna
@ast
Daniele Sanna
@en
Daniele Sanna
@es
Daniele Sanna
@nl
type
label
Daniele Sanna
@ast
Daniele Sanna
@en
Daniele Sanna
@es
Daniele Sanna
@nl
prefLabel
Daniele Sanna
@ast
Daniele Sanna
@en
Daniele Sanna
@es
Daniele Sanna
@nl
P106
P1153
36500364800
P31
P496
0000-0001-9299-0141